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Summary Several diseases are known or suspected to be associated with altered levels of hormones and growth factors that may influence
breast cancer risk. To elucidate this possibility, we studied the relationship between 23 medical conditions or procedures and breast cancer
risk by means of data from a multicentric case-control study conducted between 1991 and 1994 in six Italian areas. The study included 2569
histologically confirmed incident cases of breast cancer (median age 55 years, range 23-74 years) and 2588 control women (median age
56 years, range 20-74 years) admitted to the same hospitals as cases for a variety of acute conditions unrelated to known or suspected risk
factors for breast cancer. After allowance for education, parity and body mass index, elevated odds ratios (ORs) emerged for history of
diabetes mellitus in post-menopausal women (OR = 1.5, 95% Cl 1.1-2.0), hypertension in pregnancy (OR = 1.8, 95% Cl 1.0-3.4) and breast
nodules (OR = 1.3, 95% Cl 1.0-1.7). Risk decreases were associated with ovarian ablation for ovarian cysts (OR = 0.5, 95% Cl 0.3-0.7) and
with thyroid nodules (OR = 0.7, 95% Cl 0.5-0.9) but not with the combination of any type of benign thyroid disease. While most examined
conditions seemed unrelated to breast cancer risk, the association with late-onset diabetes is of special interest as it suggests a role of
hyperinsulinaemia and insulin resistance in breast cancer promotion. It also points to preventive lifestyle modifications.
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It has been hypothesized that breast cancer risk is determined by
cell proliferation in response to sex hormones (Henderson et al,
1988) and possibly other hormones (e.g. thyroid hormones;
Stewart et al, 1990) and growth factors [i.e. insulin-like growth
factor (IGF-I); Kazer, 1995].
In post-menopausal women, the involvement of oestrogens is
suggested by the association of breast cancer with several
hormone-related characteristics (e.g. age at menopause, parity,
being overweight, etc.) (Franceschi et al, 1996a; Talamini et al,
1996). Several investigators found that post-menopausal women
who subsequently developed breast cancer tended to show higher
levels ofoestrone, total and free oestradiol and a lower per cent of
oestradiol bound to sex-hormone binding globulin (SHBG) than
women who remained free of cancer (Toniolo et al, 1995;
Lipworth et al, 1996). SHBG concentration determines oestrogen
bioavailability and is influenced by several physiological and
pathological conditions. Obesity, forinstance, increases peripheral
aromatization of androgens but also reduces SHBG concentration
(Enriori and Reforzo-Membrives, 1984). Insulin and IGF-I are
powerful negative regulators of SHBG synthesis in vitro and
may stimulate breast cancer proliferation in several ways
(Macaulay, 1992). In the presence of functioning ovaries (i.e.
premenopausal women), the peripheral aromatization of andro-
gens is relatively unimportant and the association between
female hormones and breast cancer risk has been shown less
consistently than in post-menopausal women (Key and Pike, 1988;
Helzlsouer et al, 1994).
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A variety of diseases are known or suspected to cause or to be
associated with modifications of hormones and/or growth factors
and have, therefore, been studied with respect to breast cancer risk.
To furtherelucidate theseissues, we have taken advantage ofalarge
multicentre case-control study on breast cancer carried out in Italy.
SUBJECTS AND METHODS
The data were derived from a case-control study on breast cancer
conducted between June 1991 and February 1994 in six Italian
areas: the provinces of Pordenone and Gorizia; the urban areas of
Milan and Genoa and the province of Forli in northern Italy; the
province of Latina near Rome in central Italy; and the urban area
of Naples in southern Italy. The emphasis of the study was on
dietary habits and the methods have been described previously
(Franceschi et al, 1996b).
Briefly, cases were women with incident, histologically
confirmed breast cancer diagnosed within the year before inter-
view and admitted to the major teaching and general hospitals in
the study areas. A total of2569 cases below 75 years (median age
55 years, range 23-74 years) were included in the present
analyses. Controls were women resident in the same geographical
areas and admitted for acute conditions to the same network of
hospitals as the cases. The interviewers visited selected wards of
these hospitals on defined days and interviewed all eligible
subjects, excluding those admitted for gynaecological, hormonal,
metabolic or neoplastic diseases. A total of 2588 controls below
age 75 (median age 56 years, range 20-74 years), admitted to
hospital for a wide spectrum of acute diseases (22% trauma, 33%
other orthopaedic disorders, 16% acute surgical conditions, 18%
eye disorders and 12% other diseases) were interviewed. On
average, fewer than 4% ofcases and controls approached for inter-
view refused to participate.
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Table 1 Odds ratios (OR) and 95% confidence intervals (CI)a of breast cancer according to history of selected medical conditions or procedures by menopausal
status and overall. Italy, 1991-94
Premenopausal women Post-menopausal women All
Condition/procedure Cases-controls OR (95% C) Cases-Controls OR (95%C) OR (95% C)
Diabetes mellitus 11:11 0.9 (0.4-2.0) 106:88 1.5 (1.1-2.0) 1.4 (1.0-1.8)
Hypertension (any time) 86:62 1.2 (0.9-1.8) 439:470 1.0 (0.9-1.2) 1.1 (0.9-1.3)
Hypertension in pregnancy 13:8 1.4 (0.6-3.4) 15:8 2.3 (1.0-5.4) 1.8 (1.0-3.4)
Hyperlipidaemia 91:57 1.4 (1.0-2.0) 367:393 1.0 (0.9-1.2) 1.1 (0.9-1.2)
Gallstones 66:73 0.8 (0.5-1.1) 253:296 0.9 (0.8-1.1) 0.9 (0.8-1.1)
Allergy 104:92 0.9 (0.7-1.3) 174:153 1.3 (1.0-1.6) 1.1 (0.9-1.3)
Oesophagitis 10:6 1.1 (0.4-3.0) 18:17 1.2 (0.6-2.4) 1.1 (0.6-2.0)
Gastroduodenal ulcer 47:34 1.1 (0.7-1.8) 95:95 1.1 (0.8-1.5) 1.1 (0.9-1.4)
Intestinal poliposis 4:3 0.8 (0.2-3.9) 13:16 0.9 (0.4-1.9) 0.9 (0.5-1.8)
Breast nodule (fibroadenoma) 65:33 1.6 (1.0-2.5) 107:96 1.2 (0.9-1.6) 1.3 (1.0-1.7)
Fibrocystic mastopathy 75:50 1.1 (0.7-1.6) 71:56 1.4 (0.9-2.0) 1.2 (0.9-1.6)
Previous breast biopsies 21:13 1.3 (0.6-2.6) 23:17 1.4 (0.8-2.7) 1.3 (0.8-2.1)
Thyroid nodule (adenoma) 20:39 0.4 (0.2-0.7) 56:74 0.9 (0.6-1 .2)b 0.7 (0.5-0.9)
Goitre 11:7 1.3 (0.5-3.4) 25:29 0.9 (0.5-1.6) 1.0 (0.6-1.6)
Hyperthyroidism 25:20 0.8 (0.5-1.5) 45:45 1.1 (0.7-1.7) 1.0 (0.7-1.4)
Hypothyroidism 5:7 0.7 (0.2-2.2) 13:18 0.7 (0.3-1.4) 0.6 (0.3-1.2)
Any benign thyroid diseases 69:70 0.7 (0.5-1.1) 151:173 0.9 (0.7-1.2) 0.9 (0.7-1.1)
Uterine leiomyomas 85:68 1.0 (0.7-1.3) 260:311 0.9 (0.7-1.1) 0.9 (0.8-1.1)
Endometriosis 5:7 0.6 (0.2-1.8) 18:14 1.6 (0.8-3.2) 1.1 (0.6-2.0)
Ovarian cysts 41:51 0.7 (0.4-1.0) 78:130 0.6 (0.5-0.8) 0.6 (0.5-0.8)
Pelvic inflammatory disease 16:12 1.2 (0.5-2.6) 19:24 0.9 (0.5-1.6) 0.9 (0.6-1.5)
Stein-Leventhal syndrome 8:8 1.0 (0.4-2.8) 6:8 0.8 (0.3-2.4) 0.8 (0.4-1.7)
Physician-diagnosed subfertility 28:32 0.8 (0.5-1.4) 41:38 1.1 (0.7-1.8) 0.9 (0.7-1.3)
aEstimates from multiple logistic regression equation including terms for study area, age, education, parity, body mass index and, in overall analyses,
menopausal status. bTest of interaction between condition or procedure and menopausal status (Wald chi-square test) P < 0.03.
The structured questionnaire included information on personal
characteristics and habits, education and other socioeconomic
factors, general lifestyle, such as smoking, alcohol and coffee
consumption, a validated food frequency consumption section, a
few indicators of physical activity, menstrual and reproductive
history. Past histories of 23 selected medical conditions or proce-
dures and age at firstdiagnosis (orperformance) were also elicited
(Table 1).
Odds ratios (ORs), andcorresponding 95% confidence intervals
(CIs) were obtained via unconditional multiple logistic regression
models (Schlesselman, 1982). Women with breast cancer were
significantly more educated, reported fewer full-term pregnancies
and were more often premenopausal than control subjects
(Talamini et al, 1996). Body mass index (BMI), computed as
weight (in kg) divided by height (in m2) was inversely associated
with breast cancer risk in premenopausal women but was directly
associated in post-menopausal ones (Franceschi et al, 1996a). To
allow for the possible confounding or modifying effect of these
factors, theregressionequationsincluded, besidesdesign variables
(i.e. study area and age in quinquennia), terms for education (<6,
7-11, . 12 years), parity (0, 1, 2, 3, .4) and quintile ofBMI.
On account of the different risk patterns, major analyses are
presented separately for premenopausal women (989 cases and
843 controls) andpost-menopausal ones (i.e. non-pregnant women
who had not reported a menstrual period within the last 12 months
or had undergone hysterectomy and/or bilateral oophorectomy;
1580 cases and 1745 controls). Interaction terms between
menopausal status and history of various medical conditions or
procedures were evaluated by means of the Wald chi-square test.
RESULTS
Table 1 shows the relationship between history of 23 medical
conditions and procedures and breast cancerrisk, overall and sepa-
rately in pre- and post-menopausal women. In most, no significant
association was found. History ofdiabetes mellitus, however, was
associated with a 40% increased risk (OR = 1.4, 95% CI 1.0-1.8).
The association with diabetes seemed restricted to post-
menopausal women (OR = 1.5, 95% CI 1.1-2.0). Prior diagnosis
of hypertension was unrelated to breast cancer risk. However, an
association was found with first diagnosis of hypertension during
pregnancy (OR = 1.4, 95% CI 0.6-3.4 in premenopausal women
and OR = 2.3, 95% CI 1.0-5.4 in post-menopausal women) but
was based on only 28 cases and 16 controls with positive history.
Elevated risks were seen in women who reported breast nodules,
fibrocystic mastopathy and breast biopsies but was significant
only for breast nodules (OR = 1.3, 95% CI 1.0-1.7), most notably
in premenopausal women (OR = 1.6, 95% CI 1.0-2.5). History of
hyperlipidaemia seemed a risk factor in premenopausal women
(OR = 1.4, 95% CI 1.0-2.0).
History of thyroid nodules and ovarian cysts were associated
with significantly decreased breast cancer risk. OR for thyroid
nodules was reduced only in premenopausal women (OR = 0.4,
95% CI 0.2-0.7), and the interaction term with menopausal status
was significant. However, when history of any benign thyroid
disease was examined to avoid recall difficulties, no relationship
was evident with breast cancer risk (OR = 0.9, 95% CI 0.7-1.1)
(Table 1). ORs below unity were found in pre- as well as post-
menopausal women who reported ovarian cysts (OR = 0.6, 95%
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Table 2 Odds ratios (OR) and 95% confidence intervals (CI)a of breast cancer according to age at diagnosis of selected medical conditions. Italy, 1991-1994
Age at diagnosis (years)
Condition < 35 35-54 >55
Cases-controls OR (95% CI) Cases-controls OR (95% CI) Cases-controls OR (95%CI)
Diabetes mellitus 10:13 0.8 (0.3-1.9) 39:49 0.9 (0.6-1.4) 68:37 2.2 (1.5-3.3)
Hypertension (any time) 45:26 1.7 (1.0-2.8) 269:266 1.1 (0.9-1.3) 211:240 1.0 (0.8-1.2)
Thyroid nodule (adenoma) 14:32 0.4 (0.2-0.8) 44:58 0.8 (0.5-1.1) 18:23 0.9 (0.5-1.6)
Ovarian cysts 57:101 0.5 (0.4-0.8) 57:69 0.8 (0.5-1.1) 5:11 0.5 (0.2-1.4)
Breast nodule (fibroadenoma) 49:40 1.2 (0.8-1.8) 102:70 1.4 (1.0-2.0) 22:19 1.3 (0.7-2.4)
aEstimates from multiple logistic regression equation, including terms for study area, age, education, parity, body mass index and menopausal status.
CI 0.5-0.8), but the apparent protection was restricted to those
who underwent ovarian ablation for this condition (OR = 0.5, 95%
CI 0.3-0.7). Few cases and controls reported physician-treated
subfertility. A similar distribution was also found overall and with
respect to specific major causes of subfertility, such as hormonal
imbalances (18 cases and 15 controls) and salpingeal occlusion (12
cases and 18 controls). Stein-Leventhal syndrome was reported by
14 breast cancer cases and 16 control subjects.
In order to elucidate the time pattern of the above mentioned
associations, ORs were reassessed according to age at first diag-
nosis or procedure and years before breast cancer diagnosis or
interview (for controls). Conditions that were significantly associ-
ated with breast cancer risk overall or in any specific stratum of
age at onset are shown in Table 2. The association with diabetes
was restricted to late-onset diabetes, i.e. > 55 years (OR = 2.2, 95%
CI 1.5-3.3). Conversely, risk decreases associated with thyroid
nodules and ovarian cysts seemed stronger with early disease onset
(i.e. < 35 years). Women who reported hypertension below age 35
(pregnancy included), but not afterwards, had a 70% increased risk
(95% CI 1.04-2.8). Risk elevations associated with breast nodules
were similar in different age groups (Table 2). With respect to the
latency orrecency ofthe priordiagnoses orprocedures (i.e. < 10 or
. 10 years before diagnosis), ORs were, in all instances, similar
(not shown).
As diabetes was correlated with obesity (i.e. fifth quintile of
BMI), and obesity was a risk factor for breast cancer in post-
menopausal women in our study, we examined the effect of
diabetes separately in obese and non-obese women. Elevated ORs
were seen for diabetic post-menopausal women in both strata
(OR = 1.3, 95% CI 0.8-2.1 in obese women and OR = 1.6,
95% CI 1.1-2.4 in non-obese women).
Results were consistent when all medical conditions and proce-
dures were reassessed separately in each ofthe six study areas and
in comparison to major categories of control women (i.e.
orthopaedic and traumas/other) one by one.
DISCUSSION
Our study had the power to detect relatively small differences
between breast cancer cases and controls (e.g. 90% power of
detecting 40% increases or decreases ofrisk with about 5-10% of
affected persons among controls) (Schlesselman, 1982). The
hospital-based study design does not seem to have caused selec-
tion bias; the prevalence of medical conditions among control
women was similar to that found in the Italian National Health
Survey based on 90 000 subjects representative of the whole
Italian population (e.g. prevalence of diabetes around 40 per 1000
in the female adultpopulation; Negri et al, 1988). Conversely, with
respect to recall bias and data quality, the performance ofall inter-
views in a hospital setting probably assured more complete ascer-
tainment of medical history and closer similarity between cancer
cases and controls than that obtainable in a community setting
(Kelly et al, 1990). Furthermore, interview information could be
supplemented with medical record data, thus minimizing the risk
offalse negatives.
The twofold increased risk in women with late-onset diabetes
(i.e. most likely type-2 non-insulin-dependent diabetes) is of
interest. Case-control and cohort studies have notprovided consis-
tent evidence for an association between breast cancer risk and
diabetes (Adami and Rimsten, 1978; Ragozzino et al, 1982;
O'Mara et al, 1985; Franceschi et al, 1990a; Kopp et al, 1990;
Adami et al, 1991; Moseson et al, 1993; La Vecchia et al, 1994)
but, in the lack of information about the type and severity of
diabetes, the interpretation of their findings is not clear (Kaaks,
1996). In a case-control investigation on subclinical diabetes,
hyperinsulinaemia with insulin resistance was a significant risk
factor for breast cancer, independent ofweight or body fat distrib-
ution (Bruning et al, 1992). Hyperinsulinaemia, as in late-onset
diabetes, may promote breast cancer, as insulin is an important
growth factor for human breast cancercells (Freiss et al, 1990) and
elevated insulin receptor contents have been found in breast cancer
specimens (Papa et al, 1990). Furthermore, insulin levels are
inversely related to SHBG levels and, thus, positively related to
available oestrogens and androgens. In our study, the adverse
effect of diabetes was not accounted for by the effect of obesity
which was, in post-menopausal women, of similar direction but
somewhat weaker (Franceschi et al, 1996a). Central (i.e. high
waist-to-hip ratio) obesity has been suggested to be associated
with a greater degree of insulin resistance than lowerbody obesity
(Kazer, 1995). Waist-to-hip ratio, however, was not correlated with
either breast cancer risk (Franceschi et al, 1996b) or history of
diabetes in our data. Finally, independent support to the
insulin/breast cancer hypothesis comes from the dietary findings
of our study which showed that a diet high in refined carbohy-
drates and low in vegetables led to increased breast cancer risk
possibly by means of a combination of high glycaemic load and
insulin resistance (Giovannucci, 1995; Franceschi et al, 1996b).
Women who reported benign breast disease and/or breast biop-
sies showed ORs of 1.2-1.3. This estimate is somewhat lower, but
compatible, with those from previous investigations, generally in
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the order oftwo (Franceschi et al, 1990a; Dupont et al, 1994; Levi
et al, 1994). A better recall in cases than controls and the difficulty
of excluding diagnoses and procedures linked to breast cancer
diagnosis may well have led to some overestimation of the
association in some studies.
Hypertension has seemed to be associated with increased breast
cancer risk in a few studies (De Waard and Baanders-van
Halewijn, 1974; Tornberg etal, 1988) but not in others (Franceschi
et al, 1990a; Moseson et al, 1993). Our study suggests some
adverse influence of early-onset hypertension, particularly when
the first manifestation coincided with a full-term pregnancy.
Results were, however, based on only a few dozen women with
this condition. Hints ofselective breast cancerincreases forhyper-
tension at an early age emerged also from two case-control studies
(Franceschi et al, 1990a; Moseson et al, 1993). Conversely,
Thompson etal (1989) found thatdiagnosis ofhypertension before
the end of the most recent pregnancy reduced breast cancer risk
(OR=0.7).
A relationship between thyroid disease and breast cancer has
been suggested (Stewart et al, 1990). Moderate increased risks of
breast cancer following thyroid cancer and of thyroid cancer
following breast cancerhave been reported (Ron et al, 1984). Such
associations, however, may reflect biases as a result of increased
medical surveillance and shared socioeconomic and reproductive
risk factors between the two malignancies (Ron et al, 1984;
Franceschi et al, 1990b). Most prospective and case-control
studies have not found evidence that prior diagnosis of thyroid
disease affects breast cancer risk (Kalache et al, 1982; Brinton et
al, 1984; Goldman etal, 1990, 1992). Weak, butinconsistent, asso-
ciations between specific thyroid diseases and breast cancer risk
have occasionally emerged (Moseson et al, 1993), as in our study,
but were generally compatible with chance (Brinton et al, 1984;
Goldman et al, 1992).
With respect to the apparent protection shown by ovarian cysts,
more frequent anovulatory menstrual cycles might have been an
explanation, as they have been reported to reduce breast cancer
risk (Henderson et al, 1988). No risk decrease was, however, seen
in our study in women who did not undergo ovarian ablation.
Protection is therefore likely to derive from the marked reduction
of serum level of female hormones caused by ovarian ablation
(Irwin et al, 1988) and not by history of ovarian cysts per se.
Polycystic ovaries (Stein-Leventhal syndrome), the most common
cause of excessive androgen production in anovulatory women
and a purported predisposing condition for breast cancer (Kazer,
1995), were rare both among cases and controls in our study. One
investigation (Gammon and Thompson, 1991) showed a signifi-
cantly protective effect of polycystic ovaries. Also, physician-
treated subfertility did not show an association, in agreement with
some cohort study data (Brinton et al, 1989), but not with a
case-control study (Moseson et al, 1993). Although in our study
few women reported physician-treated subfertility, it has been
shown elsewhere (Talamini et al, 1996) that the length of attempt
to first pregnancy was similar in cases and in controls.
In conclusion few medical conditions showed significant asso-
ciations with breast cancer risk. Evidence of an adverse influence
of diabetes in post-menopausal women are of special interest. As
insulin resistance is partly modifiable by means ofincreased phys-
ical activity (Helmrich et al, 1991), nutritional changes (Smith,
1994) and body weight control (Mayer et al, 1996), this finding
has implications for prevention.
ACKNOWLEDGEMENTS
This workwas conducted within theframeworkoftheCNR (Italian
National Research Council) Applied Project 'Clinical Applications
of Oncological Research' (contracts no. 96.00701.PF39 and
96.00759.PF39) and 'Risk Factors for Disease' (contract no.
95.00952.PF41) and with the contributions of the Italian
Association forResearch on Cancer andtheEurope Against Cancer
Program of the Commission of European Communities. The
authors wish to thank Mrs Anta Redivo for editorial assistance.
REFERENCES
Adami HO and Rimsten A (1978) Prevalence ofhypertension and diabetes in breast
cancer: a case-control study in 179 patients and age-matched, non-hospitalized
controls. Clin Oncol 4: 243-249
Adamni HO, McLaughlin J, Ekbom A, Berne C, Silverman D, Hacker D and Persson
1(1991) Cancer risk in patients with diabetes mellitus. Cancer Causes Control
2: 307-314
Brinton LA, Hoffman DA, Hoover R and Fraumeni JF Jr (1984) Relationship of
thyroid disease and use ofthyroid supplements to breast cancer risk. J Chron
Dis 37: 877-883
Brinton LA, Melton LJ III, Malkasian GD, Bond A and Hoover R (1989) Cancer
risk after evaluation for infertility. Am JEpidemiol 129: 712-722
Bruning PF, Bonfrer JMG, van Noord PAH, Hart AAM, De Jong-Bakker M and
Nooijen WJ (1992) Insulin resistance and breast-cancer risk. IntJ Cancer 52:
511-516
De Waard R and Baanders-van Halewijn EA (1974) A prospective study in general
practice on breast-cancer risk in menopausal women. IntJ Cancer 14: 153-160
Dupont WD, Page DL, Par! FF, Vnencak-Jones CL, Plummer WD, Rados MS and
Schuyler PA (1994) Long-term risk ofbreast cancer in women with
fibroadenoma. NEngl JMed331: 10-15
Enriori CL and Reforzo-Membrives J (1984) Peripheral aromatization as a risk
factor for breast and endometrial cancer in postmenopausal women: a review.
Gynecol Oncol 17: 1-21
Franceschi S, La Vecchia C, Negri E, Parazzini F and Boyle P (1990a) Breast cancer
risk and history ofselected medical conditions linked with female hormones.
EurJCancer 26: 781-785
Franceschi S, Fassina A, Talamini R, Mazzolini A, Vianello S, Bidoli E and La
Vecchia C (1990b) The influence ofreproductive and hormonal factors on
thyroid cancer in women. Rev Epidemiol Sante Publique 38: 27-34
Franceschi S, Favero A, La Vecchia C, Baron AE, Negri E, Dal Maso L, Giacosa A,
Montella M, Conti E and Amadori D (1996a) Body size indices and breast
cancer risk before and after menopause. IntJCancer 67: 181-186
Franceschi S, Favero A, Decarli A, Negri E, La Vecchia C, Ferraroni M, Russo A,
Salvini S, Amadori D, Conti E, Montella M and Giacosa A (1996b) Intake of
macronutrients and risk ofbreast cancer. Lancet347: 1351-1356
Freiss G, Prebois C, Rochefort H and Vignon F (1990) Anti-steroidal and anti-
growth factor activities ofanti-estrogens. JSteroidBiochem 37: 777-781
Gammon MD and Thompson WD (1991) Polycystic ovaries and the risk ofbreast
cancer. Am JEpidemiol 134: 818-824
Giovannucci E (1995) Insulin and colon cancer. Cancer Causes Control 6: 164-179
Goldman MB, Monson RR and MaloofF (1990) Cancer mortality in women with
thyroid disease. Cancer Res 50: 2283-2289
Goldman MB, Monson RR and MaloofF (1992) Benign thyroid diseases and the
risk ofdeath from breast cancer. Oncology 49: 461-466
Helmrich SP, Ragland DR, Leung RW and Paffenbarger RS (1991) Physical activity
and reduced occurrence ofnon-insulin-dependent diabetes mellitus. NEnglJ
Med325: 147-152
Helzlsouer KJ, Alberg AJ, Bush TL, Longcope C, Gordon GB and Comstock GW
(1994) A prospective study ofendogenous hormones and breast cancer. Cancer
Detection Prevention 18: 79-85
Henderson BE, Ross R and Bernstein L (1988) Estrogens as a cause ofhuman
cancer: the Richard and Hinda Rosenthal Foundation Award Lecture. Cancer
Res 48: 246-253
Irwin KL, Lee NC, Peterson HB, Rubin GL, Wingo PA and Mandel MG (1988)
Hysterectomy, tubal sterilization, and the risk ofbreast cancer. Am JEpidemiol
127: 1192-1201
Kaaks R (1996) Nutrition, hormones, and breast cancer: is insulin the missing link?
Cancer Causes Control 7: 605-625
British Journal ofCancer (1997) 75(11), 1699-1703 0 CancerResearch Campaign 1997Medical conditions andbreast cancer 1703
Kalache A, Vessey MP and McPherson K (1982) Thyroid disease and breast cancer:
findings in a large case-control study. Br J Surg 69: 434-435
Kazer RR (1995) Insulin resistance, insulin-like growth factor I and breast cancer: a
hypothesis. Int J Cancer 62: 403-406
Kelly JP, Rosenberg L, Kaufman DW and Shapiro S (1990) Reliability ofpersonal
interview data in a hospital-based case-control study. Am J Epidemiol 131:
79-90
Key TJA and Pike MC (1988) The role ofoestrogens and progestagens in the
epidemiology and prevention of breast cancer. Eur J Clin Oncol 24: 29-43
Kopp S, Tanneberger S, Mohner M and Kieser R (1990) Diabetes and breast cancer
risk. IntJ Cancer 46: 751-752
La Vecchia C, Negri E, Franceschi S, D'Avanzo B and Boyle P (1994)
A case-control study ofdiabetes mellitus and cancer risk. Br J Cancer 70:
950-953
Levi F, Randimbison L, Te V-C and La Vecchia C (1994) Incidence of breast cancer
in women with fibroadenoma. Int J Cancer 57: 681-683
Lipworth L, Adami H-O, Trichopoulos D, Carlstrom K and Mantzoros C (1996)
Serum steroid hormone levels, sex hormone-binding globulin, and body mass
index in the etiology ofpostmenopausal breast cancer. Epidemiology 7: 96-100
Macaulay VM (1992) Insulin-like growth factors and cancer. Br J Cancer 65:
311-320
Mayer EJ, Newman B, Austin MA, Zhang D, Quesenberry CP, Edwards K and Selby
JV (1996) Genetic and environmental influences on insulin levels and the
insulin resistance syndrome: an analysis of women twins. Am J Epidemiol 143:
323-332
Moseson M, Koenig KL, Shore RE and Pastemack BS (1993) The influence of
medical conditions associated with hormones on the risk of breast cancer. Int J
Epidemiol 22: 1000-1009
Negri E, Pagano R, Decarli A and La Vecchia C (1988) Body weight and the
prevalence ofchronic disease. J Epidemiol Commun Health 42: 24-29
O'Mara BA, Byers T and Schoenfeld E (1985) Diabetes mellitus and cancer risk: a
multi-site case-control study. J Chron Dis 38: 435-441
Papa V, Pezzino V, Costantino A, Belfiore A, Giuffrida D, Frittitta L, Vannelli GB,
Brand R, Goldfine ID and Vigneri R (1990) Elevated insulin receptor content in
human breast cancer. J Clin Invest 86: 1503-1510
Ragozzino M, Melton LI, Chu CP and Palumbo PJ (1982) Subsequent cancer risk in
the incidence cohort ofRochester, Minnesota, residents with diabetes mellitus.
J Chron Dis 35: 13-19
Ron E, Curtis R, Hoffman DA and Flannery JT (1984) Multiple primary breast and
thyroid cancer. Br J Cancer 49: 87-92
Schlesselman JJ (1982) Case-Control Studies. Design, Conduct, Analysis.
Monographs in Epidemiology and Biostatistics. Oxford University Press: New
York
Smith U (1994) Carbohydrates, fat, and insulin action. Am J Clin Nutr 59:
686S-689S
Stewart AJ, Johnson MD, May FEB and Westley BR (1990) Role of insulin-like
growth factors and the type I insulin-like growth factor receptor in the
estrogen-stimulated proliferation ofhuman breast cancer cells. J Biol Chem
265: 21172-21178
Talamini R, Franceschi S, La Vecchia C, Negri E, Borsa L, Montella M, Falcini F,
Conti E and Rossi C (1996) The role ofreproductive and menstrual factors in
cancer ofthe breast before and after menopause. Eur J Cancer 32A: 303-310
Thompson WD, Jacobson HI, Negrini B and Janerich DT (1989) Hypertension,
pregnancy, and risk ofbreast cancer. JNatl Cancer Inst 81: 1571-1574
Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, Banerjee S, Koenig KL, Shore RE,
Strax P and Pastemack BS (1995) A prospective study ofendogenous estrogens
and breast cancer in postmenopausal women. JNatl Cancer Inst87: 190-197
Tornberg SA, Holm LE and Carstensen JM (1988) Breast cancer risk in relation to
serum cholesterol, serum beta-lipoprotein, height, weight, and blood pressure.
Acta Oncologica 27: 31-37
@ CancerResearch Campaign 1997 British Journal ofCancer (1997) 75(11), 1699-1703